Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by fredgoodwinsonon Sep 07, 2019 3:40am
156 Views
Post# 30104792

RE:RE:RE:RE:RE:RE:RE:Can we soon start treating terminal children ( brain cancer

RE:RE:RE:RE:RE:RE:RE:Can we soon start treating terminal children ( brain cancer

Thanks Eog - didn`t hear back from Lazer00 with his alleged toxicity issues but if TLD-1433 is safe Rutherrin is safer and a lot of preclinical work in GBM has confirmed this as per my previous post. 

 

 

There are at least two other legs - vaccine and CLT - to TLT`s GBM Treatment.These were the further subject of separate papers at that International Congress (see below).

 

 

 

Paper 11070-110: A New Platform Technology RuVaCare™, an Extracorporeal Anti-Cancer Vaccine is Efficient in Breaking Immune Barrier to Target Cancer Cells 

 

This paper discusses the successful application of Theralase®'s PDT technology as a cancer vaccine, known as RuVaCare™, and highlights the study's outcome and the significant increase of survival obtained in the RuVaCareTM vaccinated RG2-GBM model. RuVaCare™ was designed to break the suppressive tumours barriers and to selectively boost the activation of an effective immune response, specifically toward malignant cancer cells. 

 

 

Paper 11070-353: Photobiomodulation Inhibits Warburg Metabolism and Potentiates a Dose Dependent Response By GBM Cells to Ruthenium-Based PDT 

 

This paper discusses the impact of Photo Bio Modulation ("PBM") on the Warburg Effect and how it increases the efficacy of TLD-1433 in the destruction of GBM brain tumours.

 

If the PDT alone can push survival out beyond 5 years` then in combination with vaccine and CLT  (leaving aside for now cannabis) results should be spectacular. PDT is repeatable not only within the 16 hour window of the therapeutic dwell-time but as a separate procedure at a later date.  The serious prospect of a non-invasive treatment to defeat this terrible disease.

 
Bullboard Posts